Abstract The GHRP-2 10mg peptide pen offers a high-concentration, high-capacity format of Pralmorelin (Growth Hormone Releasing Peptide-2). As a synthetic agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R1a), GHRP-2 is distinguished by its superior potency compared to first-generation secretagogues. While it shares the somatotropic efficacy of GHRP-6, it exhibits a significantly reduced orexigenic (appetite-stimulating) profile. This 10mg formulation is specifically designed for longitudinal studies, high-throughput screening, or research involving larger animal models where lower-concentration reagents would require frequent replacement or excessive injection volumes. It serves as the standard for investigating the upper limits of pituitary secretory capacity and the synergistic potential of combinatorial peptide therapies.

Mechanism and Research Interest

Primary Biological Pathway: GHS-R1a Mediated Exocytosis GHRP-2 acts via the GHS-R1a receptor located on the pituitary somatotrophs and the hypothalamus. Unlike GHRH, which utilizes the cAMP pathway, GHRP-2 activates the Phospholipase C (PLC) pathway, leading to the generation of IP3​ and Diacylglycerol (DAG). This triggers a massive release of intracellular calcium stores, causing the fusion of GH-containing secretory vesicles with the plasma membrane. Research utilizing the 10mg pen is critical for “saturation studies,” allowing researchers to determine the maximal secretory capacity (Vmax​) of the pituitary gland under varying physiological conditions.

Secondary Research Finding: Synergistic Amplification The primary utility of GHRP-2 in modern research is in “synergy protocols.” When co-administered with a GHRH analogue (like Mod GRF 1-29), the resulting GH pulse is not merely additive but exponential. The 10mg format allows for the preparation of high-concentration stock for these co-administration studies, ensuring that the GHRP component remains sufficient throughout long-duration experiments aimed at mimicking youthful pulsatile profiles in senescent models.

Tertiary Research Finding: Stress Hormone Modulation GHRP-2 possesses a slightly broader receptor affinity profile than Ipamorelin. At high dosages, it can stimulate the release of ACTH (cortisol) and Prolactin. While often minimized in metabolic research, this property is invaluable for neuro-endocrine stress testing. The 10mg pen enables “challenge tests” to assess the sensitivity of the corticotropic axis and to evaluate the safety margins between anabolic efficacy and stress-response activation.

Long-term Genomic and Safety Observations Chronic administration of secretagogues can lead to receptor downregulation. Genomic studies utilizing the 10mg dose investigate the transcriptional regulation of the Ghsr gene. By maintaining consistent high-dose exposure, researchers can map the timeline of desensitization and evaluate the efficacy of “pulsatile” versus “continuous” dosing regimens in maintaining receptor density.

Product Specifications

• Purity: Validated at >98+% via High-Performance Liquid Chromatography (HPLC). The synthesis process ensures the preservation of the D-2-Naphthylalanine residue, which is critical for the peptide’s enhanced binding affinity and metabolic stability.

• Appearance: The 3ml pen contains a clear, colourless, sterile liquid.

• Precision: The pen delivery system ensures accurate volumetric dosing. The 10mg concentration allows for the delivery of higher molar loads in smaller volumes, reducing injection site trauma in small animal models.

• Storage: The product must be stored at 2∘C to 8∘C.

Storage and Shipping Guidelines

Refrigeration and Shelf Life The GHRP-2 10mg Pen contains a concentrated peptide solution that requires refrigeration (2∘C to 8∘C). The shelf life is 12 months in the sealed state. Once the pen is accessed, the bacteriostatic environment preserves the solution for 28 days. Researchers should note that the higher concentration of the 10mg pen offers slightly improved stability against surface adsorption compared to more dilute preparations, but cold-chain maintenance remains mandatory.

Shipping Stability We utilize medical-grade thermal packaging. The peptide is stable for up to 72 hours at ambient UK temperatures. However, to ensure the highest fidelity for receptor interaction studies, we recommend selecting the fastest available shipping option.

Freezing Warning Do not freeze. Freezing can cause the peptide to precipitate out of the solution, leading to concentration gradients. Upon thawing, the solution may not regain homogeneity, resulting in erratic dosing data. A frozen pen should be discarded.

Why Choose the Peptide Pro 3ml Pen Format?

The GHRP-2 10mg Pen is the definitive tool for High-Throughput and Longitudinal Research. For studies requiring chronic administration (e.g., 8-12 weeks) or larger cohorts, standard 5mg vials are depleted too quickly, introducing variability between batches and increasing the risk of contamination during frequent changeovers.

Our 10mg pen provides a high-capacity, sterile, and concentration-verified source. It ensures that a single device can sustain a longer treatment protocol or a larger sample group, reducing experimental variables and improving the statistical power of your data.

For researchers optimizing their secretagogue protocols, we recommend examining:

• CJC-1295 No DAC 10mg:  (The essential partner for synergistic GH release).

• Ipamorelin 10mg: (For comparative studies requiring a highly selective, non-cortisol stimulating control).

Disclaimer

This product is strictly for Research Use Only (RUO). It is not intended for human consumption, injection (e.g., for bodybuilding, anti-aging, or performance enhancement), therapeutic use, or diagnostic procedures. The information provided is for educational and scientific reference only. Purchase is restricted to verified research institutions and qualified individuals. Any evidence of intended misuse for human application will result in immediate order cancellation and blacklisting, in compliance with UK research chemical regulations.